Labshake search
Citations for R&D Systems :
1 - 50 of 2403 citations for Tumor necrosis factor receptor superfamily member 3 TNFRSF3 Human HEK293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... tumor necrosis factor alpha (TNFα; R&D systems, 210-TA), Lactate dehydrogenase (LDH ...
-
bioRxiv - Cell Biology 2019Quote: ... Tumor necrosis factor-alpha (TNFα) were obtained from R&D Systems. Cathepsin Inhibitor 1 (S2847) ...
-
bioRxiv - Physiology 2020Quote: ... tumor necrosis factor α (TNF-α; R&D Systems, Minneapolis, MN), interleukin 6 (IL-6 ...
-
bioRxiv - Biophysics 2020Quote: ... 10ng/mL recombinant tumor necrosis factor-α (TNF-α, R&D Systems), and 100ng/mL of recombinant interferon-γ (IFN-γ ...
-
bioRxiv - Immunology 2021Quote: ... and tumor necrosis factor (TNF)α (R&D Systems®, LXSAHM-04). Briefly ...
-
bioRxiv - Cell Biology 2023Quote: ... or tumor necrosis factor alpha (TNFα, 20 ng/mL, R&D systems) were used as positive controls.
-
bioRxiv - Systems Biology 2022Quote: ... mouse tumor necrosis factor alpha (TNF-α; R&D Systems, aa 80-235), mouse interleukin 1 beta (IL-1β ...
-
bioRxiv - Neuroscience 2019Quote: ... 30 ng/mL tumor necrosis factor alpha (R&D Systems; 210-TA-020) and 400 ng/mL C1q (MyBioSource ...
-
bioRxiv - Bioengineering 2023Quote: ... Supernatant was probed for tumor necrosis factor alpha (TNFα, R&D Systems, mta006), IL10 (Invitrogen ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50ng/ml tumor necrosis factor α (TNFα, R&D Systems #410-MT-025).
-
bioRxiv - Immunology 2021Quote: ... tumor necrosis factor (TNF)-α (25 ng/mL; R&D Systems Cat# 210-TA), and polyinosinic:polycytidylic acid (20 ng/mL ...
-
bioRxiv - Bioengineering 2023Quote: ... and levels of tumor necrosis factor-α (TNF-α) were assessed by ELISA within 3 days (DY410; R&D Systems). The cytokines TNF-α ...
-
bioRxiv - Cell Biology 2019Quote: ... Q-VD-OPh and Tumor Necrosis Factor-alpha (TNFα) were obtained from R&D Systems. Ionomycin was purchased from Calbiochem ...
-
bioRxiv - Cell Biology 2022Quote: ... but supplemented with 30ng/μl tumor necrosis factor alpha (TNFα; R&D systems, #210-TA-020) for 7d ...
-
bioRxiv - Biochemistry 2023Quote: ... 20 ng/mL recombinant mouse tumor necrosis factor-α (TNF-α) (R&D Systems, 41-0MT0-25CF) and 12 ng/mL recombinant mouse IFN-γ were added to the media.
-
bioRxiv - Cell Biology 2023Quote: ... The concentration of tumor necrosis factor α (TNFα) in supernatants was determined using TNFα ELISA Kit (R&D Systems, USA) and Nunc MaxiSorp ELISA Plates (Thermo Fisher Scientific ...
-
bioRxiv - Bioengineering 2022Quote: ... cells were treated on either brain or vascular channel with TNF-α (Tumor Necrosis Factor-α, R&D Systems; 210-TA). The treatment was initiated after the formation of a confluent monolayer at ∼5 days in culture ...
-
bioRxiv - Immunology 2020Quote: ... 511 or 111 coated filters and stimulated for 4 h with 5nM tumor necrosis factor-α (TNF-α; R&D Systems), then human monocytes or monocyte Hoxb8 cells were added ...
-
bioRxiv - Microbiology 2022Quote: ... cell media was replaced with media containing the compound and 20 ng/mL tumor necrosis factor alpha TNF-α (R&D Systems).
-
bioRxiv - Neuroscience 2019Quote: ... for 24h or with 10 ng/mL tumor necrosis factor alpha and 10ng/ml IL1-ß(R&D Systems; 401-ML-005) for 24h ...
-
bioRxiv - Immunology 2019Quote: ... normal T cell expressed and secreted (RANTES) and tumor necrosis factor alpha (TNF-α) by ELISA (R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions ...
-
bioRxiv - Immunology 2021Quote: ... 50 ng/mL of recombinant human GM-CSF (Sanofi-aventis Cat# NAC2004–5843-01) and 2.5 ng/mL of tumor necrosis factor (TNF)-α (25 ng/mL; R&D Systems Cat# 210-TA). Next ...
-
bioRxiv - Biophysics 2023Quote: ... A “type-1” like cytokine cocktail consisted of 10 ng/ml of recombinant mouse tumor necrosis factor-α (TNF-α, R&D Systems, Minneapolis, MN), 5 ng/ml of recombinant mouse interleukin-1β (IL-1β ...
-
bioRxiv - Bioengineering 2023Quote: RFP-MDA-MD-231 and GFP-HUVEC at 3 million/mL and 8 million/mL in precursor solution were photopatterned and perfused using the peristaltic pump previously mentioned at 0.2 rpm/mL for five days before tumor necrosis factor-alpha (TNF-α) (R&D Systems, Minneapolis, MN, USA) and Vascular endothelial growth factor (VEGF ...
-
bioRxiv - Immunology 2019Quote: We measured the concentrations of IL-1β and tumor necrosis factor alpha (TNF-α) in culture supernatants by using a commercial ELISA kit (R&D Systems, Minneapolis, MN, USA).
-
bioRxiv - Microbiology 2019Quote: Serum concentrations of tumor necrosis factor-α (TNF-α) and interleukin1β (IL-1β) were measured on 8th week using Valukine™ immunoassay kits (R&D Systems, Inc., Minneapolis, USA) according to the manufacturer’s instructions using microplate reader (Synergy 2 ...
-
bioRxiv - Neuroscience 2023Quote: ... Tumour necrosis factor (TNF) was quantified using a DuoSet ELISA kit (catalogue # DY410-05, R&D Systems, UK) according to the manufacturer’s instructions.
-
bioRxiv - Cell Biology 2023Quote: ... HEK293-derived human Shh (R&D Systems, 8908-SH) served as a bioactivity control and to quantify Bosc23-expressed ...
-
bioRxiv - Genomics 2019Quote: ... and 10 ng/ml recombinant human transforming growth factor beta 3 (rhTGF-b3) (R&D Systems). Pellets were formed at the end of passage 6 ...
-
bioRxiv - Neuroscience 2023Quote: ... member 3A (Wnt3A) (10 ng/mL, R&D Systems) and cyclopamine (1 μM ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human Soluble Receptor Array (R&D Systems, Minneapolis, MN, # ARY012) was performed according to a manufacturer protocol ...
-
bioRxiv - Developmental Biology 2019Quote: ... goat anti-Platelet derived growth factor receptor beta (PDGFRB, 1:1000, AF1042, R&D systems), rat anti-Plasmalemma vesicle associated protein (PLVAP ...
-
bioRxiv - Developmental Biology 2021Quote: ... goat anti-platelet derived growth factor receptor-beta (PDGFRB, 1:1000, AF1042, R&D Systems), goat anti-notch3 (NOTCH3 ...
-
bioRxiv - Immunology 2021Quote: ... IL-6 and tumour necrosis factor (TNF) in the supernatant were analysed by enzyme-linked immunosorbent assay (ELISA; DuoSet, R&D systems) according to the manufacturer’s instructions.
-
bioRxiv - Bioengineering 2021Quote: ... and 100 U/mL Penicillin/Streptomycin supplemented with 0.1% recombinant human Fetal Growth Factor b (Alamone F-170) and 0.1% recombinant human Epidermal Growth Factor (R&D systems 236-EG). On Day 12 ...
-
bioRxiv - Neuroscience 2020Quote: ... and goat anti-platelet derived growth factor receptor-alpha (PDGFRα, R&D systems #AF1062, 1:200), in a PBS-based diluent buffer containing 10% normal donkey serum and 0.2% Triton-X100 ...
-
bioRxiv - Molecular Biology 2021Quote: ... recombinant human epidermal growth factor (R&D systems, USA); IFN-γ (Cell Sciences ...
-
bioRxiv - Molecular Biology 2024Quote: ... Resting or ADP (10 μM)-stimulated platelets (4 × 103/μL) were pretreated with the inhibitor hDcR3 (10 μg/mL, recombinant human decoy receptor 3 protein, R&D Systems) for 10 min and then allowed to adhere to the coated coverslips for 60 min at RT under normoxic or hypoxic conditions ...
-
bioRxiv - Cancer Biology 2023Quote: Human Phospho-Receptor Tyrosine Kinase Array Kit (R&D Systems, Cat#ARY001B) and Proteome Profiler Human Phospho-Kinase Array Kit (R&D Systems ...
-
bioRxiv - Neuroscience 2019Quote: ... goat anti-platelet derived growth factor receptor-α (PDGFRα, 1:200, AF1062. R&D Systems, MN, USA), goat anti-Iba1 (1:200 ...
-
bioRxiv - Genetics 2023Quote: ... and receptor activator of nuclear factor kappa-B ligand (RANKL) (2 ng/mL; R&D systems; USA) to induce osteoclastogenesis ...
-
bioRxiv - Neuroscience 2020Quote: ... recombinant human brain-derived neurotrophic factor (BDNF; R&D systems), and nerve growth factor (NGF) ...
-
bioRxiv - Neuroscience 2020Quote: ... recombinant human basic fibroblast growth factor (bFGF; R&D systems), fibroblast growth factor-8 (FGF-8 ...
-
bioRxiv - Cell Biology 2019Quote: ... 50 ng/ml human epidermal growth factor (R&D systems), 15 nM gastrin ...
-
bioRxiv - Systems Biology 2021Quote: ... 50ng/mL human fibroblastic growth factor 10 (R&D system), 5% FBS ...
-
bioRxiv - Biochemistry 2022Quote: ... with human recombinant nerve growth factor β (R&D Systems) and with bovine histone III (Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2023Quote: ... Human Fc-fusion constructs of each receptor were purchased from R&D Systems (TGFβRII-Fc ...
-
bioRxiv - Cancer Biology 2023Quote: ... The ligands used were His-Tagged human CD38 (R&D systems, catalog # 2404-AC ...
-
bioRxiv - Molecular Biology 2022Quote: ... 50 ng/mL recombinant human stem cell factor (R&D systems), 3 IU/mL Epoetin-alfa (Amgen) ...
-
bioRxiv - Biochemistry 2022Quote: ... recombinant human nerve growth factor-β (R&D Systems, Minneapolis, MIN); LysM (from Enterococcus faecalis ...